Medrol Dose Packs for Post-Operative Pain Control
- Registration Number
- NCT06453083
- Lead Sponsor
- University of Utah
- Brief Summary
The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.
- Detailed Description
Post-operative pain control following AIS surgery is challenging. Sub-optimal pain management results in emotional distress and prolonged hospital length of stay. Previous studies have shown that a short course of steroids following spine surgery is safe and improves pain control. To better understand the effects of the addition of steroids to a routine pain management strategy, a randomized prospective study with and without steroids will determine the benefit, if any, to the addition of steroids to the investigators already used pain protocol.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 57
- age range of 10-21
- received AIS surgery
- participants out of the age range 10-21
- other forms of scoliosis (not AIS)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo tablets Placebo Encapsulated placebo tablets per day (dosage for day 1 following the surgery is 32mg, day 2 is 24mg, day 3 is 16mg, day 4 is 12mg, day 5 is 8mg and day 6 is 4mg.) Medrol tablets Medrol Encapsulated steroid Medrol tablets (dosage for day 1 following the surgery is 32mg, day 2 is 24mg, day 3 is 16mg, day 4 is 12mg, day 5 is 8mg and day 6 is 4mg)
- Primary Outcome Measures
Name Time Method Visual Analog Scale (VAS) pain Day 6, post (AIS) surgery VAS pain score (0 no pain - 10 severe pain)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Utah Orthopaedic Center
🇺🇸Salt Lake City, Utah, United States